Key result
Plasma PTX3 and CRP levels are similar in polycystic ovary syndrome versus healthy controls.
Why the study?
PCOS patients have increased subclinical inflammation contributing to atherosclerosis, and the role of PTX3 as a cardiovascular risk marker in PCOS is unclear.
Are plasma PTX3 levels elevated as a cardiovascular risk marker in patients with PCOS compared to healthy controls?
Case-Control (n=80)
Are plasma PTX3 levels elevated as a cardiovascular risk marker in patients with PCOS compared to healthy controls?
PTX3 and CRP levels do not appear to be elevated in PCOS patients compared to matched controls, suggesting they may not be specific cardiovascular risk markers for this condition.
Answers are grounded in this paper and cite their sources.
PTX3 and CRP levels similar in PCOS versus controls; does not support their role as specific CV risk markers and leaves open prospective validation.
BACKGROUND/AIMS: Polycystic ovary syndrome (PCOS) patients have an increased rate of subclinical inflammation, which plays a role in the pathogenesis of atherosclerosis. Pentraxin 3 (PTX3) is an inflammatory mediator which belongs to the same family as the well-established cardiovascular biomarker C-reactive protein (CRP). The present study was performed to investigate plasma PTX3 levels in patients with PCOS and to determine the relationship between PTX3 and other known cardiovascular risk factors. METHODS: 40 patients with PCOS and 40 age- and BMI-matched healthy controls were included in the study. The groups were divided into subgroups according to BMI. Insulin resistance indexes, lipid profile, CRP and PTX3 levels were analyzed. RESULTS: There was no difference for insulin resistance indexes and lipid profile between the PCOS and control groups. CRP levels were significantly higher in obese PCOS and control subjects than in lean subjects, whereas no difference in PTX3 concentrations was observed between subgroups. CONCLUSION: PTX3 and CRP levels were similar in the PCOS group compared with the non-PCOS control group.
No takes yet. Share an insight, caveat, or question.
Sarı et al. (2014) conducted a case-control in Polycystic ovary syndrome (PCOS) (n=80). Polycystic ovary syndrome (PCOS) vs. Healthy controls was evaluated on Plasma PTX3 and CRP levels. Plasma pentraxin 3 (PTX3) and C-reactive protein (CRP) levels were similar in patients with polycystic ovary syndrome compared with healthy controls.
Synapse has enriched 10 related papers. Consider them for comparative context: